AzTrials
AzTrials

Cognitive DysfunctionMINDNCT04079075

Multiple Interventions to Prevent Cognitive Decline

A study testing Cognitive training, Physical activity and Nutrition education in people with Cognitive Dysfunction and Cognition Disorders, run by Universidade do Porto at 1 site in Portugal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators aim to test the feasibility of a pragmatic non-pharmacological strategy, that may prevent cognitive decline in patients with mild cognitive impairment. This strategy is based on five different interventions: cognitive training, physical activity, nutrition education, adaption to memory loss… Read more about this study

Who is it for?
Ages 18 to 85 years
What is being tested?
Cognitive training, Physical activity and Nutrition education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 sitePortugal
Study dates
1 Sep 2019to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-85 years;
  • b1) Montreal Cognitive Assessment score ≥ to two standard deviations below the normative reference value for the corresponding age and education level in the Portuguese population;
  • OR
  • b2) clinical diagnosis of Mild Cognitive Impairment;
  • Cardiovascular Risk Factors, Aging and Dementia Dementia Risk Score ≥ six points.

Who cannot join

  • medical disability that contraindicates physical activity;
  • lack of autonomy in daily activities.

Trial locations and contacts

1 site in 1 country.

João Firmino-Machado, MD, PhD contact

+351 910961236

jfdmachado@arsnorte.min-saude.pt

Portugal1 site
  • Agrupamento de Centros de Saúde do Porto Ocidental

    Porto

    João Firmino-Machado, MD, PhD, +351 910961236, jfdmachado@arsnorte.min-saude.pt

Other trials in Portugal

About this study

The investigators aim to test the feasibility of a pragmatic non-pharmacological strategy, that may prevent cognitive decline in patients with mild cognitive impairment. This strategy is based on five different interventions: cognitive training, physical activity, nutrition education, adaption to memory loss, diagnosis and correction of hearing impairment.

A quasi-experimental study will be implemented in Porto (Portugal), including patients that fulfill all of the following criteria: a) age 18-85 years; b) Montreal Cognitive Assessment (MoCA) score greater than or equal to two standard deviations below the normative reference value for the corresponding age and education level in the Portuguese population OR diagnosis of Mild Cognitive Impairment, performed by a Neurologist, during the six previous months, considering the results of a neuropsychological battery; c) Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Dementia Risk Score of at least six points. Patients who have any medical disability that contraindicates physical activity or have a lack of autonomy in daily activities will be excluded.

The program will be implemented in groups of 10 participants, over a period of 10 consecutive months.

Read the detailed description

Detailed description

This is a quasi-experimental study in which the investigators aim to test the feasibility of a non-pharmacological strategy to prevent cognitive decline in patients with a diagnosis of mild cognitive impairment. This strategy is based on five different interventions:

  1. Cognitive training

This comprises training using using the cogweb software, both in person and remotely:

  1. in person training: 30-minute sessions, supervised by a trained nurse, twice weekly . ii) remote training: unsupervised 30-minute sessions, to be performed at home at the participants will.
  2. Physical activity This is based on 60-minute sessions including aerobic, resistance, agility/balance and flexibility exercises, directed by a physical education teacher and supervised by a nurse, twice weekly.
  3. Nutrition education

This is based on monthly 180-minute sessions, directed by a nutritionist, comprising:

  1. Presentation and discussion of healthy and easy to cook recipes by the nutritionist; ii) Preparation of healthy meals by the participants, followed by a period of social interaction between the participants while consuming the meals prepared.
  2. Adaptation to memory loss This is based on monthly 30-minute sessions, directed by a psychologist or a nurse, who will provide strategies that participants may use in their daily life to cope with memory loss.
  3. Diagnosis of hearing impairment Before implementing the sessions of cognitive training, physical activity, nutrition education and adaption to memory loss, an audiologist will perform an audiogram to all participants. Those with auditive performance inferior to the reference values will be referred for a medical appointment with an otolaryngologist.

Strategies (a),(b), (c) and (d) will be implemented over a period of 10 months, in groups of 10 participants.

Being tested
Cognitive training, Physical activity, Nutrition education, Adaption to memory loss, Diagnosis of hearing impairment
Keywords
Correction of Hearing Impairment, Cognitive Dysfunction, Diet, Healthy, Exercise Therapy, Cognition Disorders, Neuropsychological Tests, Hearing Loss, Memory Disorders, Cognitive Remediation, Non-Randomized Controlled Trials as Topic
Medical subject headings
Cognitive Dysfunction, Cognition Disorders, Memory Disorders, Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive trainingOther

    This comprises training using using the cogweb software, both in person and remotely:

    1. in person training: 30-minute sessions, supervised by a trained nurse, twice weekly . ii) remote training: unsupervised 30-minute sessions, to be performed at home at the participants will.
  • Physical activityBehavioural

    This is based on 60-minute sessions including aerobic, resistance, agility/balance and flexibility exercises, directed by a physical education teacher and supervised by a nurse, twice weekly.

  • Nutrition educationBehavioural

    This is based on monthly 180-minute sessions, directed by a nutritionist, comprising:

    1. Presentation and discussion of healthy and easy to cook recipes by the nutritionist; ii) Preparation of healthy meals by the participants, followed by a period of social interaction between the participants while consuming the meals prepared.
  • Adaption to memory lossBehavioural

    This is based on monthly 30-minute sessions, directed by a psychologist or a nurse, who will provide strategies that participants may use in their daily life to cope with memory loss.

  • Diagnosis of hearing impairmentDiagnostic test

    Before implementing the sessions of cognitive training, physical activity, nutrition education and adaption to memory loss, an audiologist will perform an audiogram to all participants. Those with auditive performance inferior to the reference values will be referred for a medical appointment with an otolaryngologist.

Study groups in NCT04079075
Study groupRoleWhat they receive
Non-pharmacological interventionExperimentalNon-pharmacological strategy, implemented in groups of 10 participants, over 10 consecutive months, based on five different interventions: cognitive training, physical activity; nutrition education; adaption to memory loss; detection and correction of hearing impairment.
Receives: Other: Cognitive training; Behavioral: Physical activity; Behavioral: Nutrition education; Behavioral: Adaption to memory loss; Diagnostic Test: Diagnosis of hearing impairment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive performance 1

    Variation of participant's cognitive performance assessed using the Montreal Cognitive Assessment, between the baseline assessment and the end of follow-up. This scale varies from 0 (worst cognitive performance) to 30 points (best cognitive performance).

    Measured: 10 months

  2. Body mass index

    Variation of participant's body mass index between the baseline assessment and the end of follow-up.

    Measured: 10 months

  3. Adherence to the Mediterranean diet

    Variation of participant's self-reported adherence to the Mediterranean diet, assessed using the Mediterranean food pattern (PREDIMED) scale, between the baseline assessment and the end of follow-up. This scale varies from 0 (lowest adherence to the Mediterranean diet) to 14 points (highest adherence to the Mediterranean diet). A score over 10 points indicates good adherence to the Mediterranean diet.

    Measured: 10 months

  4. Number of steps

    Variation of participant's number of steps, assessed using a portable accelerometer, between the baseline assessment and the end of follow-up.

    Measured: 10 months

  5. Adherence to each intervention

    Proportion of adherence to each intervention and component of each intervention, calculated as the number of sessions attended/total number of sessions implemented. For remote cognitive training the outcome will be the absolute number of sessions.

    Measured: 10 months

  6. Dropout

    Proportion of participants who dropped out of the study, calculated as the number of participants who dropped out after attending at least one session/total number of participants who attended at least one session.

    Measured: 10 months

Secondary outcomes (10)
  1. Cognitive performance 2

    Variation of participant's cognitive performance assessed using a neuropsychological battery, between the baseline assessment and the end of follow-up. This will be reported in the format of a Z-score, assuming positive and negative values. Higher scores indicate better cognitive performance.

    Measured: 10 months

  2. Memory complaints

    Variation of the self-reported memory complaints, assessed using the self-reported memory complaints scale, between the baseline assessment and the end of follow-up. This scale varies from 0 (best score) to 21 points (worst score). Scores over three points indicate the presence of self-reported memory complaints.

    Measured: 10 months

  3. Anxiety and depression

    Variation of the anxiety and depression scores, assessed using the Hospital Anxiety and Depression Scale (HADS), between the baseline assessment and the end of follow-up. This scale varies from 0 (best score) to 21 points (worst score).

    Measured: 10 months

  4. Reported quality of life: EQ-5D scale

    Variation of participant's quality of life, assessed using the EuroQol Group scale - 5 dimensions (EQ-5D) scale, between the baseline assessment and 10 months after the beginning of the intervention. This is assessed using two subscales: a) five multiple choice questions, with five response possibilities, which produce a score that varies from 5 (best score) to 25 points (worst score); b) visual analogic scale, that varies from 0 (worst score) to 100 (best score).

    Measured: 10 months

  5. Handgrip strength

    Variation of participant's handgrip strength, assessed using a dynamometer, between the baseline assessment and 10 months after the beginning of the intervention.

    Measured: 10 months

  6. Agility 1

    Variation of participant's agility and balance, assessed using the Time Up and Go Test scale, between the baseline assessment and 10 months after the beginning of the intervention. This is measured in time units (seconds) and varies from 0 (best score) to infinite (worst score).

    Measured: 10 months

  7. Agility 2

    Variation of participant's agility and balance, assessed using the One Leg Balance Test, between the baseline assessment and 10 months after the beginning of the intervention. This is measured in time units (seconds) and varies from 0 (best score) to infinite (worst score).

    Measured: 10 months

  8. Time of follow-up

    Number of days between the first and the last session attended by the participant.

    Measured: 10 months

  9. Implemented sessions

    Proportion of sessions implemented, calculated as the number of sessions that the research team was able to implement/total number of sessions planned.

    Measured: 10 months

  10. Complete assessment of participants

    For each study outcome, proportion of participants with complete information, calculated at baseline and different moments of follow-up, as the number of participants with complete information/total number of participants evaluated.

    Measured: 10 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Sep 2019
  2. Study start1 Sep 2019 (estimated)
  3. Primary completionAug 2020 (estimated)
  4. Study completionDec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04079075
Sponsor's protocol ID
EPIUnit_MIND_2019
Acronym
MIND
Status last verified
Aug 2019
First submitted
28 Aug 2019
Last updated
6 Sep 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive training, Physical activity and Nutrition education in people with Cognitive Dysfunction and Cognition Disorders, run by Universidade do Porto at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact João Firmino-Machado, MD, PhD (+351 910961236, jfdmachado@arsnorte.min-saude.pt), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive performance 1 (time frame: 10 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in